Clinical trial
Trial of SAVVY Vaginal Gel and HIV in Nigeria
NCT00130078 · Biosyn, Industry · Unknown status
Key facts
| NCT number | NCT00130078 |
|---|---|
| Title | Trial of SAVVY Vaginal Gel and HIV in Nigeria |
| Official title | Randomized Controlled Trial of SAVVY and HIV in Nigeria |
| Lead sponsor | Biosyn, Industry |
| Collaborators | FHI 360 United States Agency for International Development (USAID) U.S. Fed |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | 1.0% C31G SAVVY vaginal gel |
| Enrollment | 2,142 |
| Start date | Sep 1, 2004 |
| First posted | Aug 15, 2005 |
| Last update posted | Sep 26, 2005 |
| Countries | Nigeria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: